Zhang X, Li S, Niu S. ACE2 and COVID-19 and the resulting ARDS. Postgrad Med J 2020;96:403–7. doi: 10.1136/postgradmedj-2020-137935.

Sieñko J, Kotowski M, Bogacz A, et al. COVID-19: the influence of ACE genotype and ACE-I and ARBs on the course of SARS-CoV-2 infection in elderly patients. Clin Interv Aging 2020;15:1231-40. doi: 10.2147/CIA.S261516.

CDC COVID-19 Response Team, Bialek S, Boundy E, Bowen V, et al. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) — United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:343-6. doi: 10.15585/mmwr.mm6912e2.

Karyono DR, Wicaksana AL. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. JCEMPH 2020;3:77-84. DOI: 10.22146/jcoemph.57325.

Fulop T, Dupuis G, Witkowski JM, Larbi A. The role of immunosenescence in the development of age-related diseases. Rev Invest Clin 2016;68:84-91.

Jergoviæ M, Coplen CP, Uhrlaub JL, Nikolich-Žugich J. Immune response to COVID-19 in older adults. J Heart Lung Transplant 2021;40:1082-9. doi: 0.1016/j.healun.2021.04.017.

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–42. doi:10.1001/jama.2020. 2648.

Dhama K, Patel SK, Kumar R, et al. Geriatric population during the COVID-19 pandemic: problems, considerations, exigencies, and beyond. Front Public Health 2020;8:574198. doi: 10.3389/fpubh.2020.574198.

Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections? Front Physiol 2021;11: 571416. doi: 10.3389/fphys.2020.571416.

Perrotta F, Corbi G, Mazzeo G, et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res 2020; 32:1599-608. doi: 10.1007/s40520-020-01631-y.

Malone ML, Hogan TM, Perry A, et al. COVID-19 in older adults: key points for emergency department providers. Geriatric Emergency Department Collaborative. J Geriatr Emerg Med 2020;1:1-11.

Torres Acosta MA, Singer BD. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population. Eur Respir J 2020;56:2002049. doi: 10.1183/13993003.02049-2020.

Koff WC, Williams MA. Covid-19 and immunity in aging populations — a new research agenda. N Engl J Med 2020;383:804–5. doi: 10.1056/NEJMp2006761.

Bencivenga L, Rengo G, Varricchi G. Elderly at time of COrona Virus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition. Geroscience 2020;42:1089-92. doi: 10.1007/s11357-020-00218-9.

Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect 2020;80:e14-e8. doi: 10.1016/j.jinf.2020.03.005.

Heneghan C, Aronson J, Mahtani K. Rapidly managing pneumonia in older people during a pandemic. Oxford COVID-19 Centre for Evidence Based-Medicine; 2020.

Yang JW, Yang L, Luo RG, Xu JF. Corticosteroid administration for viral pneumonia: COVID-19 and beyond. Clin Microbiol Infect 2020;26:1171-7. doi: 10.1016/j.cmi.2020.06.020.

Matera MG, Rogliani P, Calzetta L, Cazzola M. Pharmacological management of COVID-19 patients with ARDS (CARDS): a narrative review. Respir Med 2020;171:106114. doi: 10.1016/j.rmed. 2020.106114.

Fischer F, Raiber L, Boscher C, Winter MHJ. COVID-19 and the elderly: who cares? Front Public Health 2020;8:151. doi: 10.3389/fpubh. 2020.00151.

Azzolino D, Saporiti E, Proietti M, Cesari M. Nutritional considerations in frail older patients with COVID-19. J Nutr Health Aging 2020;24:696–8. doi: 10.1007/s12603-020-1400-x.

Fernández-Quintela A, Milton-Laskibar I, Trepiana J, et al. Key Aspects in nutritional management of COVID-19 patients. J Clin Med 2020;9:2589. doi: 10.3390/jcm9082589.

Rolles B, Maywald M, Rink L. Influence of zinc deficiency and supplementation on NK cell cytotoxicity. J Funct Foods 2018;48:322-8. https://doi.org/10.1016/j.jff.2018.07.027.